marketcaparena
Search

    AHCO

    AdaptHealth Corp.

    Company overview

    Market capitalization
    $770.34M
    Employees
    10,900
    Latest publication
    2026-09-29
    About AdaptHealth Corp.

    AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20232023-03-31 · USDQ1 20222022-03-31 · USDQ4 20212021-12-31 · USDQ3 20212021-09-30 · USDQ2 20212021-06-30 · USDQ1 20212021-03-31 · USDQ4 20192019-12-31 · USD
    Total Revenue740,307,000USD744,626,000USD524,553,000USD702,106,000USD472,782,000USD617,017,000USD482,119,000USD149,541,000USD
    Cost Of Revenue636,101,000USD655,396,000USD597,122,000USD591,620,000USD529,887,000USD490,720,000USD396,698,000USD123,212,000USD
    Gross Profit104,206,000USD89,230,000USD-72,569,000USD110,486,000USD-57,105,000USD126,297,000USD85,421,000USD26,329,000USD
    General And Administrative Expenses96,093,000USD———————
    Total Operating Expenses242,008,000USD63,053,000USD-124,121,000USD41,407,000USD-132,815,000USD60,890,000USD70,012,000USD25,615,000USD
    Operating Income-137,802,000USD26,177,000USD51,552,000USD69,079,000USD75,710,000USD65,407,000USD15,409,000USD714,000USD
    Total Other Income Expense Net-27,531,000USD-11,216,000USD-3,719,000USD-35,584,000USD-5,297,000USD26,981,000USD-20,746,000USD-7,653,000USD
    Income Before Tax-165,333,000USD14,961,000USD47,833,000USD33,495,000USD70,413,000USD92,388,000USD-5,337,000USD-6,939,000USD
    Income Tax Expense-21,227,000USD-1,714,000USD5,603,000USD10,024,000USD12,147,000USD12,330,000USD-1,695,000USD-4,288,000USD
    Discontinued Operations11,387,000USD———————
    Net Income-132,719,000USD15,707,000USD41,750,000USD22,942,000USD58,092,000USD79,107,000USD-3,966,000USD-3,426,000USD
    Minority Interest1,210,000USD968,000USD480,000USD-529,000USD-174,000USD4,080,000USD4,199,000USD-14,729,012USD
    Selling General Administrative—47,521,000USD41,444,000USD34,921,000USD33,006,000USD42,946,000USD56,632,000USD24,985,000USD
    Unclassified Operating Expenses—15,532,000USD-165,565,000USD6,486,000USD-165,821,000USD17,944,000USD13,380,000USD—
    Interest Expense—31,955,000USD24,776,000USD25,611,000USD24,252,000USD23,147,000USD22,185,000USD7,653,000USD
    Net Interest Income—-31,955,000USD-24,776,000USD-25,611,000USD-24,252,000USD-23,147,000USD-22,185,000USD-43,618,049USD
    Tax Provision—-1,714,000USD5,603,000USD10,024,000USD12,147,000USD12,330,000USD-1,695,000USD281,647USD
    Net Income From Continuing Ops—16,675,000USD42,230,000USD23,471,000USD58,266,000USD80,058,000USD-3,642,000USD-12,888,749USD
    Ebit—46,916,000USD72,609,000USD59,106,000USD94,665,000USD115,535,000USD16,848,000USD31,010,947USD
    Ebitda—149,642,000USD149,639,000USD136,332,000USD164,493,000USD179,328,000USD64,054,000USD31,640,947USD
    Depreciation And Amortization—102,726,000USD77,030,000USD77,226,000USD69,828,000USD63,793,000USD47,206,000USD630,000USD
    Reconciled Depreciation—93,813,000USD77,030,000USD77,226,000USD69,828,000USD63,793,000USD13,380,000USD630,000USD
    Non Operating Income Net Other—20,739,000USD21,057,000USD-5,312,000USD8,949,000USD28,049,000USD-526,000USD—
    Net Income Applicable To Common Shares—15,707,000USD41,750,000USD22,942,000USD58,092,000USD72,199,000USD-3,966,000USD-3,425,801USD
    Interest Income———————39,304,490USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USD
    Total Revenue345,278,337USD192,559,144USD174,316,366USD
    Cost Of Revenue285,202,893USD162,900,391USD158,689,039USD
    Gross Profit60,075,444USD29,658,753USD15,627,327USD
    Selling General Administrative1,036,124USD690USD8,004,773USD
    Total Operating Expenses1,233,716USD690USD13,304,815USD
    Operating Income-1,233,716USD-690USD2,322,512USD
    Interest Income4,149,617USD——
    Interest Expense4,149,617USD0USD0USD
    Net Interest Income4,149,617USD——
    Income Before Tax2,915,901USD-690USD-3,438,844USD
    Income Tax Expense829,807USD248,808USD-208,445USD
    Tax Provision829,807USD——
    Net Income2,086,094USD-690USD-3,793,424USD
    Net Income From Continuing Ops2,086,094USD10,474,235USD-3,230,399USD
    Ebit-1,233,716USD-690USD2,322,512USD
    Ebitda7,065,518USD-690USD28,885,106USD
    Depreciation And Amortization8,299,234USD27,816,290USD26,562,594USD
    Total Other Income Expense Net4,149,617USD-5,364,811USD-5,761,356USD
    Minority Interest2,865,125USD-34,091,883USD-34,091,883USD
    Net Income Applicable To Common Shares23,260,347USD9,687,397USD-4,183,323USD
    Research Development—310,000USD—
    Selling And Marketing Expenses—482,738USD399,232USD
    Other Operating Expenses—690USD—
    Discontinued Operations—-206,632USD-389,899USD
    Unclassified Operating Expenses——4,900,810USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets4,340,869,000USD4,424,007,000USD4,316,577,000USD4,383,523,000USD4,350,825,000USD4,437,350,000USD4,486,947,000USD4,469,936,000USD
    Total Current Assets797,475,000USD687,476,000USD728,899,000USD724,824,000USD658,001,000USD745,173,000USD755,788,000USD683,791,000USD
    Other Current Assets90,219,000USD88,277,000USD100,619,000USD82,856,000USD46,926,000USD143,773,000USD98,180,000USD48,906,000USD
    Other Non Current Assets22,090,000USD———————
    Total Liabilities2,954,613,000USD———————
    Total Current Liabilities709,212,000USD743,287,000USD712,392,000USD670,696,000USD622,092,000USD576,734,000USD566,987,000USD553,025,000USD
    Other Current Liabilities4,117,000USD———————
    Other Non Current Liabilities243,805,000USD———————
    Total Stockholder Equity1,378,466,000USD1,507,074,000USD1,518,562,000USD1,616,782,000USD1,587,444,000USD1,567,799,000USD1,571,145,000USD1,516,256,000USD
    Total Equity Including Noncontrolling Interest1,386,256,000USD———————
    Short Long Term Debt8,125,000USD24,375,000USD20,313,000USD16,250,000USD16,250,000USD16,250,000USD16,250,000USD16,250,000USD
    Long Term Debt1,879,809,000USD1,798,902,000USD1,715,983,000USD1,743,930,000USD1,792,741,000USD1,941,062,000USD1,964,921,000USD2,013,644,000USD
    Deferred Revenue64,743,000USD———————
    Net Receivables390,389,000USD391,966,000USD370,897,000USD412,519,000USD393,593,000USD418,455,000USD408,019,000USD401,215,000USD
    Inventory105,480,000USD159,269,000USD151,247,000USD149,092,000USD148,852,000USD129,295,000USD139,842,000USD133,490,000USD
    Property Plant Equipment Net783,572,000USD795,075,000USD674,224,000USD628,564,000USD625,518,000USD622,436,000USD618,356,000USD620,081,000USD
    Goodwill2,370,431,000USD———————
    Intangible Assets31,780,000USD80,232,000USD85,121,000USD90,092,000USD95,174,000USD100,286,000USD105,548,000USD113,452,000USD
    Accounts Payable576,300,000USD431,948,000USD352,381,000USD341,450,000USD339,654,000USD294,331,000USD284,602,000USD266,476,000USD
    Short Term Debt36,030,000USD78,273,000USD68,743,000USD60,136,000USD59,694,000USD60,891,000USD60,510,000USD58,833,000USD
    Common Stock14,000USD14,000USD13,000USD13,000USD13,000USD13,000USD13,000USD13,000USD
    Retained Earnings-782,941,000USD-649,012,000USD-632,972,000USD-530,202,000USD-554,711,000USD-569,385,000USD-562,178,000USD-612,440,000USD
    Accumulated Other Comprehensive Income0USD—78,000USD569,000USD1,173,000USD1,578,000USD2,253,000USD1,625,000USD
    Total Liab—2,909,526,000USD2,790,253,000USD2,758,672,000USD2,756,699,000USD2,863,496,000USD2,908,829,000USD2,945,748,000USD
    Other Current Liab—173,337,000USD231,425,000USD209,257,000USD166,454,000USD175,062,000USD186,931,000USD191,874,000USD
    Capital Stock—15,000USD14,000USD14,000USD14,000USD14,000USD14,000USD14,000USD
    Good Will—2,567,365,000USD2,541,428,000USD2,653,401,000USD2,651,085,000USD2,635,434,000USD2,675,166,000USD2,707,282,000USD
    Other Assets—1USD——————
    Cash—47,964,000USD106,136,000USD80,357,000USD68,630,000USD53,650,000USD109,747,000USD100,180,000USD
    Cash And Short Term Investments—47,964,000USD106,136,000USD80,357,000USD68,630,000USD53,650,000USD109,747,000USD100,180,000USD
    Current Deferred Revenue—59,729,000USD59,843,000USD59,853,000USD56,290,000USD46,450,000USD34,944,000USD35,842,000USD
    Net Debt—1,952,743,000USD1,796,664,000USD1,823,582,000USD1,881,498,000USD2,049,619,000USD2,020,589,000USD2,078,530,000USD
    Short Long Term Debt Total—2,000,707,000USD1,902,800,000USD1,903,939,000USD1,950,128,000USD2,103,269,000USD2,130,336,000USD2,178,710,000USD
    Property Plant Equipment Gross—1,331,230,000USD1,198,372,000USD1,131,858,000USD1,128,612,000USD1,150,596,000USD1,136,532,000USD1,110,071,000USD
    Common Stock Shares Outstanding—135,779,000shares135,437,000shares137,211,000shares137,071,000shares134,799,000shares136,534,000shares136,530,000shares
    Non Current Assets Total—3,736,530,999USD3,587,678,000USD3,658,699,000USD3,692,824,000USD3,692,177,000USD3,731,159,000USD3,786,145,000USD
    Non Current Liabilities Total—2,166,238,999USD2,077,861,000USD2,087,976,000USD2,134,607,000USD2,286,762,000USD2,341,842,000USD2,392,723,000USD
    Non Current Liabilities Other—243,805,000USD243,804,000USD244,173,000USD244,173,000USD244,384,000USD272,016,000USD272,846,000USD
    Non Currrent Assets Other—18,797,999USD19,119,000USD18,721,999USD18,812,000USD18,891,000USD17,584,000USD17,153,000USD
    Net Working Capital—-55,811,000USD16,507,000USD54,128,000USD35,909,000USD168,439,000USD188,801,000USD130,766,000USD
    Unclassified Non Current Assets—275,060,999USD267,786,000USD267,920,001USD302,235,000USD315,130,000USD314,505,000USD328,177,000USD
    Unclassified Current Liabilities—-24,375,000USD-20,313,000USD-16,250,000USD-16,250,000USD-16,250,000USD-16,250,000USD-16,250,000USD
    Unclassified Non Current Liabilities—123,531,999USD118,074,000USD99,873,000USD97,693,000USD101,316,000USD104,905,000USD106,233,000USD
    Unclassified Equity—2,156,057,000USD2,151,429,000USD2,146,388,000USD2,140,955,000USD2,135,579,000USD2,131,043,000USD2,127,044,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets4,316,577,000USD4,486,947,000USD4,508,650,000USD5,219,587,000USD5,250,484,000USD1,813,472,000USD227,836,000USD254,124,282USD
    Intangible Assets85,121,000USD105,548,000USD130,160,000USD162,773,000USD202,231,000USD116,061,000USD54,801,000USD—
    Other Current Assets100,619,000USD98,180,000USD69,338,000USD52,136,000USD37,440,000USD33,441,000USD3,155,000USD-60,531,290USD
    Total Liab2,790,253,000USD2,908,829,000USD3,041,981,000USD3,061,829,000USD3,183,795,000USD1,532,627,000USD212,698,000USD8,574,393USD
    Total Stockholder Equity1,518,562,000USD1,571,145,000USD1,458,454,000USD2,151,158,000USD2,061,906,000USD354,889,000USD15,138,000USD245,549,889USD
    Other Current Liab231,425,000USD186,931,000USD195,165,000USD134,856,000USD153,551,000USD189,544,000USD23,268,000USD-27,404,001USD
    Common Stock13,000USD13,000USD13,000USD13,000USD13,000USD9,000USD7,238USD240,550,600USD
    Capital Stock14,000USD14,000USD14,000USD14,000USD14,000USD10,000USD7,238USD240,550,600USD
    Retained Earnings-632,972,000USD-562,178,000USD-652,600,000USD26,295,000USD-43,021,000USD-199,196,000USD-74,786,000USD2,085,401USD
    Good Will2,541,428,000USD2,675,166,000USD2,724,958,000USD3,545,297,000USD3,512,567,000USD998,810,000USD110,355,000USD202,436,212USD
    Cash106,136,000USD109,747,000USD77,132,000USD46,272,000USD149,627,000USD99,962,000USD9,768,000USD947,098USD
    Cash And Short Term Investments106,136,000USD109,747,000USD77,132,000USD46,272,000USD149,627,000USD99,962,000USD9,768,000USD947,098USD
    Total Current Assets728,899,000USD755,788,000USD649,022,000USD585,308,000USD670,058,000USD363,251,000USD58,106,000USD1,105,103USD
    Total Current Liabilities712,392,000USD566,987,000USD536,999,000USD456,214,000USD499,812,000USD422,053,000USD52,841,000USD699,393USD
    Current Deferred Revenue59,843,000USD34,944,000USD38,570,000USD31,641,000USD31,370,000USD11,043,000USD1,415,000USD7,508,428USD
    Net Debt1,796,664,000USD2,020,589,000USD2,217,517,000USD2,282,551,000USD2,220,969,000USD707,034,000USD151,600,000USD154,224,472USD
    Short Term Debt68,743,000USD60,510,000USD91,760,000USD67,212,000USD66,864,000USD30,428,000USD1,660,000USD27,904,380USD
    Short Long Term Debt20,313,000USD16,250,000USD53,368,000USD35,000,000USD20,000,000USD8,146,000USD1,721,132USD7,486,278USD
    Short Long Term Debt Total1,902,800,000USD2,130,336,000USD2,294,649,000USD2,328,823,000USD2,370,596,000USD806,996,000USD397,004,700USD155,171,570USD
    Long Term Debt1,715,983,000USD1,964,921,000USD2,094,614,000USD2,153,267,000USD2,183,552,000USD776,568,000USD395,111,563USD127,094,723USD
    Net Receivables370,897,000USD408,019,000USD388,910,000USD359,146,000USD359,896,000USD171,065,000USD26,970,000USD53,016,649USD
    Inventory151,247,000USD139,842,000USD113,642,000USD127,754,000USD123,095,000USD58,783,000USD18,213,000USD7,672,646USD
    Accounts Payable352,381,000USD284,602,000USD211,504,000USD222,505,000USD248,027,000USD191,038,000USD26,498,000USD40,774USD
    Property Plant Equipment Net674,224,000USD618,356,000USD637,528,000USD622,008,000USD546,337,000USD110,468,000USD2,181,000USD61,601,350USD
    Property Plant Equipment Gross1,198,372,000USD1,136,532,000USD1,074,509,000USD622,008,000USD546,337,000USD110,468,000USD63,559,080USD—
    Accumulated Other Comprehensive Income78,000USD2,253,000USD4,356,000USD8,693,000USD-2,354,000USD-4,411,000USD1,431,029USD0USD
    Common Stock Shares Outstanding135,146,000shares135,531,000shares134,418,000shares138,988,000shares133,034,000shares52,488,000shares22,557,000shares31,250,000shares
    Non Current Assets Total3,587,678,000USD3,731,159,000USD3,859,628,000USD4,634,279,000USD4,580,426,000USD1,450,221,000USD169,730,000USD253,019,179USD
    Non Current Liabilities Total2,077,861,000USD2,341,842,000USD2,504,982,000USD2,605,615,000USD2,683,983,000USD1,110,574,000USD159,857,000USD7,875,000USD
    Non Current Liabilities Other243,804,000USD272,016,000USD302,093,000USD305,501,000USD322,487,000USD220,101,000USD29,131,012USD—
    Non Currrent Assets Other19,119,000USD17,584,000USD21,128,000USD22,415,000USD15,098,000USD16,483,000USD2,393,000USD253,019,179USD
    Net Working Capital16,507,000USD188,801,000USD112,023,000USD129,094,000USD170,246,000USD-58,802,000USD30,520,638USD405,710USD
    Unclassified Non Current Assets267,786,000USD314,505,000USD345,854,000USD——-16,483,000USD-34,773,000USD-278,166,380USD
    Unclassified Current Liabilities-20,313,000USD-16,250,000USD-53,368,000USD-35,000,000USD-20,000,000USD-8,146,000USD-1,721,132USD-42,240,467USD
    Unclassified Non Current Liabilities118,074,000USD104,905,000USD108,275,000USD-197,157,000USD-202,307,000USD-95,109,000USD-293,725,575USD-122,463,562USD
    Unclassified Equity2,151,429,000USD2,131,043,000USD2,106,671,000USD2,116,143,000USD2,107,254,000USD558,477,000USD88,478,495USD-237,636,712USD
    Short Term Investments——4,482,000USD5,748,000USD———253,019,179USD
    Other Liab———344,004,000USD380,251,000USD209,014,000USD29,340,000USD3,243,839USD
    Other Assets———300,473,000USD319,291,000USD224,882,000USD34,773,000USD14,128,818USD
    Net Tangible Assets———-1,556,913,000USD-1,648,109,000USD-696,529,000USD-290,210,000USD-102,532,679USD
    Unclassified Current Assets———————-313,550,469USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-16,040,000USD-101,537,000USD22,451,000USD15,828,000USD-6,079,000USD51,403,000USD27,732,000USD20,531,000USD
    Depreciation117,305,000USD97,506,000USD109,208,000USD92,360,000USD94,345,000USD90,537,000USD90,759,000USD100,740,000USD
    Stock Based Compensation6,532,000USD5,138,000USD5,311,000USD6,131,000USD5,296,000USD4,266,000USD863,000USD5,300,000USD
    Other Non Cash Items13,659,000USD141,164,000USD12,942,000USD-18,871,000USD12,147,000USD11,876,000USD8,606,000USD876,000USD
    Change To Account Receivables-21,069,000USD8,844,000USD13,274,000USD24,297,000USD-15,429,000USD-13,912,000USD35,861,000USD-7,519,000USD
    Change To Inventory-7,751,000USD-1,742,000USD-36,000USD-18,872,000USD9,159,000USD-6,591,000USD-11,220,000USD-15,310,000USD
    Change In Working Capital-15,602,000USD40,917,000USD-18,059,000USD53,127,000USD-9,406,000USD-21,052,000USD9,884,000USD62,823,000USD
    Total Cash From Operating Activities93,722,000USD183,184,000USD161,066,000USD161,994,000USD95,527,000USD150,415,000USD144,405,000USD197,984,000USD
    Capital Expenditures-121,212,000USD-103,896,000USD-94,242,000USD-88,665,000USD-95,585,000USD-77,336,000USD-59,556,000USD-81,272,000USD
    Free Cash Flow-27,490,000USD79,288,000USD66,824,000USD73,329,000USD-58,000USD73,079,000USD84,849,000USD116,712,000USD
    Total Cashflows From Investing Activities-204,456,000USD-124,468,000USD-92,741,000USD9,604,000USD-95,585,000USD-86,872,000USD-54,240,000USD-81,272,000USD
    Net Borrowings82,833,000USD-31,299,000USD-53,833,000USD-155,125,000USD-28,221,000USD-51,604,000USD-53,371,000USD—
    Total Cash From Financing Activities52,562,000USD-32,937,000USD-56,598,000USD-156,618,000USD-56,039,000USD-53,976,000USD-59,817,000USD-126,446,000USD
    Change In Cash-58,172,000USD25,779,000USD11,727,000USD14,980,000USD-56,097,000USD9,567,000USD30,348,000USD-9,734,000USD
    Begin Period Cash Flow106,136,000USD80,357,000USD68,630,000USD53,650,000USD109,747,000USD100,180,000USD69,832,000USD79,566,000USD
    End Period Cash Flow47,964,000USD106,136,000USD80,357,000USD68,630,000USD53,650,000USD109,747,000USD100,180,000USD69,832,000USD
    Other Cashflows From Investing Activities83,244,000USD3,245,000USD1,501,000USD116,830,000USD——5,316,000USD—
    Other Cashflows From Financing Activities-30,735,000USD-1,639,000USD-3,411,000USD-738,000USD-28,382,000USD-2,372,000USD-606,000USD-3,587,000USD
    Unclassified Operating Cash Flow-12,132,000USD—29,213,000USD13,419,000USD—13,385,000USD6,561,000USD7,714,000USD
    Unclassified Investing Cash Flow-166,488,000USD-23,817,000USD92,741,000USD-28,165,000USD95,585,000USD77,336,000USD54,240,000USD81,272,000USD
    Investments——-92,741,000USD9,604,000USD-95,585,000USD-86,872,000USD-54,240,000USD-81,272,000USD
    Sale Purchase Of Stock——755,000USD-755,000USD—-272,000USD1,399,000USD-260,000USD
    Unclassified Financing Cash Flow——————-7,239,000USD-122,599,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-66,038,000USD94,780,000USD-678,895,000USD73,133,000USD158,153,000USD-58,718,000USD12,237,000USD2,086,094USD
    Depreciation381,927,000USD365,334,000USD420,594,000USD351,178,000USD258,053,000USD82,445,000USD11,283,000USD50,610,642USD
    Stock Based Compensation21,876,000USD14,880,000USD22,468,000USD22,397,000USD25,323,000USD18,670,000USD11,070,075USD884,000USD
    Other Non Cash Items150,264,000USD60,855,000USD804,203,000USD17,119,000USD-34,921,000USD97,428,000USD43,120,627USD65,911,395USD
    Change To Account Receivables30,986,000USD-26,217,000USD-28,862,000USD-209,000USD-29,694,000USD-29,517,000USD-11,811,000USD-21,341,930USD
    Change To Inventory-11,491,000USD-28,065,000USD15,531,000USD-6,300,000USD-14,920,000USD-19,434,000USD-14,259,000USD2,309,508USD
    Change In Working Capital66,579,000USD-26,059,000USD-25,109,000USD-107,996,000USD-153,309,000USD76,910,000USD-18,188,000USD429,319USD
    Total Cash From Operating Activities601,771,000USD541,839,000USD480,666,000USD373,867,000USD275,679,000USD195,634,000USD60,418,000USD68,426,808USD
    Capital Expenditures-382,388,000USD-306,055,000USD-337,463,000USD-391,423,000USD-203,308,000USD-39,755,000USD-21,332,000USD-9,949,930USD
    Free Cash Flow219,383,000USD235,784,000USD143,203,000USD-17,556,000USD72,371,000USD155,879,000USD39,086,000USD58,476,878USD
    Investments0USD-310,275,000USD-412,656,000USD-411,171,000USD-1,125,000USD-815,703,000USD-84,869,973USD-248,869,562USD
    Total Cashflows From Investing Activities-303,190,000USD-310,275,000USD-357,278,000USD-411,171,000USD-1,824,753,000USD-815,703,000USD-84,870,000USD-248,869,562USD
    Net Borrowings-268,478,000USD-179,865,000USD-51,769,000USD-36,176,000USD1,395,565,000USD354,744,000USD185,656,000USD52,764,053USD
    Total Cash From Financing Activities-302,192,000USD-198,949,000USD-92,528,000USD-66,051,000USD1,598,739,000USD643,153,000USD-13,893,000USD251,331,043USD
    Sale Purchase Of Stock0USD-2,065,999USD-29,275,000USD-13,992,000USD-3,557,000USD-44,273,000USD-20,000,000USD250,000,000USD
    Change In Cash-3,611,000USD32,615,000USD30,860,000USD-103,355,000USD49,665,000USD23,084,000USD-875,000USD827,277USD
    Begin Period Cash Flow109,747,000USD77,132,000USD46,272,000USD149,627,000USD99,962,000USD76,878,000USD10,643,000USD119,821USD
    End Period Cash Flow106,136,000USD109,747,000USD77,132,000USD46,272,000USD149,627,000USD99,962,000USD9,768,000USD947,098USD
    Other Cashflows From Investing Activities121,576,000USD5,316,000USD—-731,000USD-1,125,000USD-752,567,000USD-37,449,000USD-238,919,632USD
    Other Cashflows From Financing Activities-34,925,000USD-19,084,000USD-11,484,000USD-15,883,000USD-75,676,000USD1,842,301,000USD91,950,000USD1,505,283USD
    Unclassified Operating Cash Flow47,163,000USD32,049,000USD-62,595,000USD18,036,000USD22,380,000USD-21,101,000USD—-51,494,642USD
    Unclassified Investing Cash Flow-42,378,000USD300,739,000USD392,841,000USD392,154,000USD-1,619,195,000USD792,322,000USD58,780,973USD248,869,562USD
    Unclassified Financing Cash Flow—2,065,999USD——285,964,000USD-573,675,000USD-189,049,000USD197,061,707USD
    Issuance Of Capital Stock——0USD0USD278,850,000USD367,600,000USD145,000,000USD250,000,000USD
    Change To Liabilities———0USD-83,383,000USD136,628,000USD14,157,000USD2,691,981USD
    Dividends Paid————-3,557,000USD-935,944,000USD-82,450,000USD-250,000,000USD
    Cash And Cash Equivalents Changes————49,665,000USD23,084,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30SegmentRespiratory Health194,402,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentSleep Health386,461,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentWellness At Home159,444,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31SegmentDiabetes Health142,166,000USD0001628280-26-030602
    Q1 2026Quarterly · 2026-03-31SegmentRespiratory Health178,140,000USD0001628280-26-030602
    Q1 2026Quarterly · 2026-03-31SegmentSleep Health358,495,000USD0001628280-26-030602
    Q1 2026Quarterly · 2026-03-31SegmentWellness At Home140,998,000USD0001628280-26-030602
    Q4 2025Quarterly · 2025-12-31SegmentDiabetes Health158,533,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentRespiratory Health178,233,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentSleep Health372,271,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentWellness At Home137,252,000USDLegacy provider
    FY 2025Yearly · 2025-12-31SegmentDiabetes Health592,413,000USD0001628280-26-011213
    FY 2025Yearly · 2025-12-31SegmentRespiratory Health691,160,000USD0001628280-26-011213
    FY 2025Yearly · 2025-12-31SegmentSleep Health1,378,147,000USD0001628280-26-011213
    FY 2025Yearly · 2025-12-31SegmentWellness At Home583,137,000USD0001628280-26-011213
    Q3 2025Quarterly · 2025-09-30SegmentDiabetes Health150,075,000USD0001628280-25-048944
    Q3 2025Quarterly · 2025-09-30SegmentRespiratory Health176,996,000USD0001628280-25-048944
    Q3 2025Quarterly · 2025-09-30SegmentSleep Health354,836,000USD0001628280-25-048944
    Q3 2025Quarterly · 2025-09-30SegmentWellness At Home138,407,000USD0001628280-25-048944
    Q2 2025Quarterly · 2025-06-30SegmentDiabetes Health144,961,000USD0001628280-25-037931
    Q2 2025Quarterly · 2025-06-30SegmentRespiratory Health170,450,000USD0001628280-25-037931
    Q2 2025Quarterly · 2025-06-30SegmentSleep Health334,689,000USD0001628280-25-037931
    Q2 2025Quarterly · 2025-06-30SegmentWellness At Home150,272,000USD0001628280-25-037931
    Q1 2025Quarterly · 2025-03-31SegmentDiabetes Health138,844,000USD0001628280-26-030602
    Q1 2025Quarterly · 2025-03-31SegmentRespiratory Health165,481,000USD0001628280-26-030602
    Q1 2025Quarterly · 2025-03-31SegmentSleep Health316,351,000USD0001628280-26-030602
    Q1 2025Quarterly · 2025-03-31SegmentWellness At Home157,206,000USD0001628280-26-030602
    Q4 2024Quarterly · 2024-12-31SegmentDiabetes Health171,293,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentRespiratory Health165,322,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentSleep Health356,520,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentWellness At Home163,510,000USDLegacy provider
    FY 2024Yearly · 2024-12-31SegmentDiabetes Health614,410,000USD0001628280-26-011213
    FY 2024Yearly · 2024-12-31SegmentRespiratory Health651,150,000USD0001628280-26-011213
    FY 2024Yearly · 2024-12-31SegmentSleep Health1,349,213,000USD0001628280-26-011213
    FY 2024Yearly · 2024-12-31SegmentWellness At Home646,202,000USD0001628280-26-011213
    Q3 2024Quarterly · 2024-09-30SegmentDiabetes Health141,072,000USD0001628280-25-048944
    Q3 2024Quarterly · 2024-09-30SegmentRespiratory Health164,179,000USD0001628280-25-048944
    Q3 2024Quarterly · 2024-09-30SegmentSleep Health335,804,000USD0001628280-25-048944
    Q3 2024Quarterly · 2024-09-30SegmentWellness At Home164,803,000USD0001628280-25-048944
    Q3 2024Quarterly · 2024-09-30ProductDiabetes141,072,000USD0001628280-24-045365
    Q3 2024Quarterly · 2024-09-30ProductHealth Care Home Medical Equipment52,997,000USD0001628280-24-045365
    Q3 2024Quarterly · 2024-09-30ProductHealth Care Other74,545,000USD0001628280-24-045365
    Q3 2024Quarterly · 2024-09-30ProductHealth Care Respiratory Services164,017,000USD0001628280-24-045365
    Q3 2024Quarterly · 2024-09-30ProductHealth Care Sleep Therapy Equipment Supplies And Related Services326,447,000USD0001628280-24-045365
    Q3 2024Quarterly · 2024-09-30ProductSupplies To Home46,780,000USD0001628280-24-045365
    Q2 2024Quarterly · 2024-06-30ProductDiabetes151,189,000USD0001628280-24-035235
    Q2 2024Quarterly · 2024-06-30ProductHealth Care Home Medical Equipment53,030,000USD0001628280-24-035235
    Q2 2024Quarterly · 2024-06-30ProductHealth Care Other70,795,000USD0001628280-24-035235
    Q2 2024Quarterly · 2024-06-30ProductHealth Care Respiratory Services161,226,000USD0001628280-24-035235
    Q2 2024Quarterly · 2024-06-30ProductHealth Care Sleep Therapy Equipment Supplies And Related Services322,390,000USD0001628280-24-035235
    Q2 2024Quarterly · 2024-06-30ProductSupplies To Home47,345,000USD0001628280-24-035235
    Q1 2024Quarterly · 2024-03-31ProductDiabetes149,258,000USD0001628280-24-021191
    Q1 2024Quarterly · 2024-03-31ProductHealth Care Home Medical Equipment48,188,000USD0001628280-24-021191
    Q1 2024Quarterly · 2024-03-31ProductHealth Care Other99,251,000USD0001628280-24-021191
    Q1 2024Quarterly · 2024-03-31ProductHealth Care Respiratory Services144,936,000USD0001628280-24-021191
    Q1 2024Quarterly · 2024-03-31ProductHealth Care Sleep Therapy Equipment Supplies And Related Services306,216,000USD0001628280-24-021191
    Q1 2024Quarterly · 2024-03-31ProductSupplies To Home44,648,000USD0001628280-24-021191
    FY 2023Yearly · 2023-12-31SegmentDiabetes Health660,039,000USD0001628280-26-011213
    FY 2023Yearly · 2023-12-31SegmentRespiratory Health614,563,000USD0001628280-26-011213
    FY 2023Yearly · 2023-12-31SegmentSleep Health1,291,714,000USD0001628280-26-011213
    FY 2023Yearly · 2023-12-31SegmentWellness At Home633,861,000USD0001628280-26-011213
    Q4 2023Quarterly · 2023-12-31ProductDiabetes184,820,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductHealth Care Home Medical Equipment52,228,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductHealth Care Other92,168,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductHealth Care Respiratory Services151,005,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductHealth Care Sleep Therapy Equipment Supplies And Related Services328,765,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductSupplies To Home49,248,000USDLegacy provider
    FY 2023Yearly · 2023-12-31ProductDiabetes660,039,000USD0001628280-24-007254
    FY 2023Yearly · 2023-12-31ProductHealth Care Home Medical Equipment206,525,000USD0001628280-24-007254
    FY 2023Yearly · 2023-12-31ProductHealth Care Other301,150,000USD0001628280-24-007254
    FY 2023Yearly · 2023-12-31ProductHealth Care Respiratory Services598,820,000USD0001628280-24-007254
    FY 2023Yearly · 2023-12-31ProductHealth Care Sleep Therapy Equipment Supplies And Related Services1,241,168,000USD0001628280-24-007254
    FY 2023Yearly · 2023-12-31ProductSupplies To Home192,475,000USD0001628280-24-007254
    Q3 2023Quarterly · 2023-09-30ProductDiabetes159,937,000USD0001628280-24-045365
    Q3 2023Quarterly · 2023-09-30ProductHealth Care Home Medical Equipment52,182,000USD0001628280-24-045365
    Q3 2023Quarterly · 2023-09-30ProductHealth Care Other77,088,000USD0001628280-24-045365
    Q3 2023Quarterly · 2023-09-30ProductHealth Care Respiratory Services151,083,000USD0001628280-24-045365
    Q3 2023Quarterly · 2023-09-30ProductHealth Care Sleep Therapy Equipment Supplies And Related Services315,392,000USD0001628280-24-045365
    Q3 2023Quarterly · 2023-09-30ProductSupplies To Home48,349,000USD0001628280-24-045365
    Q2 2023Quarterly · 2023-06-30ProductDiabetes168,907,000USD0001628280-24-035235
    Q2 2023Quarterly · 2023-06-30ProductHealth Care Home Medical Equipment51,211,000USD0001628280-24-035235
    Q2 2023Quarterly · 2023-06-30ProductHealth Care Other68,133,000USD0001628280-24-035235
    Q2 2023Quarterly · 2023-06-30ProductHealth Care Respiratory Services154,080,000USD0001628280-24-035235
    Q2 2023Quarterly · 2023-06-30ProductHealth Care Sleep Therapy Equipment Supplies And Related Services302,632,000USD0001628280-24-035235
    Q2 2023Quarterly · 2023-06-30ProductSupplies To Home48,323,000USD0001628280-24-035235
    Q1 2023Quarterly · 2023-03-31ProductDiabetes146,375,000USD0001628280-24-021191
    Q1 2023Quarterly · 2023-03-31ProductHealth Care Home Medical Equipment50,904,000USD0001628280-24-021191
    Q1 2023Quarterly · 2023-03-31ProductHealth Care Other63,761,000USD0001628280-24-021191
    Q1 2023Quarterly · 2023-03-31ProductHealth Care Respiratory Services142,652,000USD0001628280-24-021191
    Q1 2023Quarterly · 2023-03-31ProductHealth Care Sleep Therapy Equipment Supplies And Related Services294,379,000USD0001628280-24-021191
    Q1 2023Quarterly · 2023-03-31ProductSupplies To Home46,555,000USD0001628280-24-021191
    FY 2022Yearly · 2022-12-31SegmentDiabetes Health687,091,000USD0001628280-25-007740
    FY 2022Yearly · 2022-12-31SegmentRespiratory Health554,141,000USD0001628280-25-007740
    FY 2022Yearly · 2022-12-31SegmentSleep Health1,103,776,000USD0001628280-25-007740
    FY 2022Yearly · 2022-12-31SegmentWellness At Home625,587,000USD0001628280-25-007740
    Q4 2022Quarterly · 2022-12-31ProductDiabetes192,207,000USDLegacy provider
    Q4 2022Quarterly · 2022-12-31ProductHealth Care Home Medical Equipment54,216,000USDLegacy provider
    Q4 2022Quarterly · 2022-12-31ProductHealth Care Other63,397,000USDLegacy provider
    Q4 2022Quarterly · 2022-12-31ProductHealth Care Respiratory Services137,206,000USDLegacy provider
    Q4 2022Quarterly · 2022-12-31ProductHealth Care Sleep Therapy Equipment Supplies And Related Services285,470,000USDLegacy provider

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.